Baidu
map

风湿免疫科

订阅

MedSci主页 / 所有栏目 / 风湿免疫科

圆桌派第一期：风湿免疫科的慢病管理与临床科研

2021-09-30 网络 网络

骨质疏松临床科研慢病管理风湿免疫
关注

风湿免疫疾病因其长病程、长生存周期和高致残留率，常给病人带来极大痛苦，也给社会带来了巨大的经济负担。

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1670454, encodeId=966916e045401, content=<a href='/topic/show?id=e2d110081540' target=_blank style='color:#2F92EE;'>#风湿免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100815, encryptionId=e2d110081540, topicName=风湿免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e49426693780, createdName=nakerunner, createdTime=Fri Mar 25 02:58:13 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679969, encodeId=444516e996951, content=<a href='/topic/show?id=f5f3100819be' target=_blank style='color:#2F92EE;'>#风湿免疫科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100819, encryptionId=f5f3100819be, topicName=风湿免疫科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae9127820432, createdName=lq0310, createdTime=Mon Mar 28 08:58:13 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057316, encodeId=e402105e3161f, content=学习了学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInOuicIVN8Y32NO4Q53Zpd86ObmNp2WIotichCD0qQHaUBeHj7hgwQBCzX7ce4aEw5ZP8icQQfLH9Zw/132, createdBy=4ec21734756, createdName=1def6e10m76(暂无匿称), createdTime=Mon Oct 04 07:05:39 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056641, encodeId=25881056641fd, content=👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211015/8d56d5fcf5414c569fbb9517e4db6199/10eae43200f34453a94bd30c453d4254.jpg, createdBy=e2255212929, createdName=14763726m01暂无昵称, createdTime=Thu Sep 30 21:04:49 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056430, encodeId=22b31056430ee, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Thu Sep 30 11:28:29 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
    2022-03-25 nakerunner

    #风湿免疫#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1670454, encodeId=966916e045401, content=<a href='/topic/show?id=e2d110081540' target=_blank style='color:#2F92EE;'>#风湿免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100815, encryptionId=e2d110081540, topicName=风湿免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e49426693780, createdName=nakerunner, createdTime=Fri Mar 25 02:58:13 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679969, encodeId=444516e996951, content=<a href='/topic/show?id=f5f3100819be' target=_blank style='color:#2F92EE;'>#风湿免疫科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100819, encryptionId=f5f3100819be, topicName=风湿免疫科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae9127820432, createdName=lq0310, createdTime=Mon Mar 28 08:58:13 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057316, encodeId=e402105e3161f, content=学习了学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInOuicIVN8Y32NO4Q53Zpd86ObmNp2WIotichCD0qQHaUBeHj7hgwQBCzX7ce4aEw5ZP8icQQfLH9Zw/132, createdBy=4ec21734756, createdName=1def6e10m76(暂无匿称), createdTime=Mon Oct 04 07:05:39 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056641, encodeId=25881056641fd, content=👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211015/8d56d5fcf5414c569fbb9517e4db6199/10eae43200f34453a94bd30c453d4254.jpg, createdBy=e2255212929, createdName=14763726m01暂无昵称, createdTime=Thu Sep 30 21:04:49 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056430, encodeId=22b31056430ee, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Thu Sep 30 11:28:29 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
    2022-03-28 lq0310

    #风湿免疫科#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1670454, encodeId=966916e045401, content=<a href='/topic/show?id=e2d110081540' target=_blank style='color:#2F92EE;'>#风湿免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100815, encryptionId=e2d110081540, topicName=风湿免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e49426693780, createdName=nakerunner, createdTime=Fri Mar 25 02:58:13 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679969, encodeId=444516e996951, content=<a href='/topic/show?id=f5f3100819be' target=_blank style='color:#2F92EE;'>#风湿免疫科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100819, encryptionId=f5f3100819be, topicName=风湿免疫科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae9127820432, createdName=lq0310, createdTime=Mon Mar 28 08:58:13 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057316, encodeId=e402105e3161f, content=学习了学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInOuicIVN8Y32NO4Q53Zpd86ObmNp2WIotichCD0qQHaUBeHj7hgwQBCzX7ce4aEw5ZP8icQQfLH9Zw/132, createdBy=4ec21734756, createdName=1def6e10m76(暂无匿称), createdTime=Mon Oct 04 07:05:39 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056641, encodeId=25881056641fd, content=👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211015/8d56d5fcf5414c569fbb9517e4db6199/10eae43200f34453a94bd30c453d4254.jpg, createdBy=e2255212929, createdName=14763726m01暂无昵称, createdTime=Thu Sep 30 21:04:49 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056430, encodeId=22b31056430ee, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Thu Sep 30 11:28:29 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
    2021-10-04 1def6e10m76(暂无匿称)

    学习了学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1670454, encodeId=966916e045401, content=<a href='/topic/show?id=e2d110081540' target=_blank style='color:#2F92EE;'>#风湿免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100815, encryptionId=e2d110081540, topicName=风湿免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e49426693780, createdName=nakerunner, createdTime=Fri Mar 25 02:58:13 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679969, encodeId=444516e996951, content=<a href='/topic/show?id=f5f3100819be' target=_blank style='color:#2F92EE;'>#风湿免疫科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100819, encryptionId=f5f3100819be, topicName=风湿免疫科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae9127820432, createdName=lq0310, createdTime=Mon Mar 28 08:58:13 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057316, encodeId=e402105e3161f, content=学习了学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInOuicIVN8Y32NO4Q53Zpd86ObmNp2WIotichCD0qQHaUBeHj7hgwQBCzX7ce4aEw5ZP8icQQfLH9Zw/132, createdBy=4ec21734756, createdName=1def6e10m76(暂无匿称), createdTime=Mon Oct 04 07:05:39 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056641, encodeId=25881056641fd, content=👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211015/8d56d5fcf5414c569fbb9517e4db6199/10eae43200f34453a94bd30c453d4254.jpg, createdBy=e2255212929, createdName=14763726m01暂无昵称, createdTime=Thu Sep 30 21:04:49 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056430, encodeId=22b31056430ee, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Thu Sep 30 11:28:29 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
    2021-09-30 14763726m01暂无昵称

    👍👍

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1670454, encodeId=966916e045401, content=<a href='/topic/show?id=e2d110081540' target=_blank style='color:#2F92EE;'>#风湿免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100815, encryptionId=e2d110081540, topicName=风湿免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e49426693780, createdName=nakerunner, createdTime=Fri Mar 25 02:58:13 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679969, encodeId=444516e996951, content=<a href='/topic/show?id=f5f3100819be' target=_blank style='color:#2F92EE;'>#风湿免疫科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100819, encryptionId=f5f3100819be, topicName=风湿免疫科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae9127820432, createdName=lq0310, createdTime=Mon Mar 28 08:58:13 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057316, encodeId=e402105e3161f, content=学习了学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInOuicIVN8Y32NO4Q53Zpd86ObmNp2WIotichCD0qQHaUBeHj7hgwQBCzX7ce4aEw5ZP8icQQfLH9Zw/132, createdBy=4ec21734756, createdName=1def6e10m76(暂无匿称), createdTime=Mon Oct 04 07:05:39 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056641, encodeId=25881056641fd, content=👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211015/8d56d5fcf5414c569fbb9517e4db6199/10eae43200f34453a94bd30c453d4254.jpg, createdBy=e2255212929, createdName=14763726m01暂无昵称, createdTime=Thu Sep 30 21:04:49 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056430, encodeId=22b31056430ee, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64745612835, createdName=zerohahaha, createdTime=Thu Sep 30 11:28:29 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
    2021-09-30 zerohahaha

    学习学习

    0

相关资讯

骨水泥什么时候打、打多少、怎么打？这篇文章解决你95%的困惑！

骨水泥作为临床常用的骨科手术材料，其渗漏也是常见的并发症，据相关文献报道，在椎体成形术中其发生率达10%~30%不等。那么如何才能处理好其渗漏问题？

JBMR：在男性骨质疏松性骨折(MrOs)研究中，肌少症是独立于FRAX®、Falls和BMD的骨折风险预测因子

双能X线骨密度仪(DXA)得出的四肢骨骼肌瘦体重/身高2(ALM/HT2)是评估骨质疏松症时最常用的肌肉质量估计方式，但其对骨折的预测价值因股骨颈(FN)骨密度(BMD)而大大减弱。

CDSR：在3-5D期慢性肾病患者中，药物干预与安慰剂、无治疗或常规护理治疗骨质疏松的比较。

慢性肾脏疾病(CKD)是骨质疏松症的独立危险因素，在CKD患者中比在无CKD患者中更为普遍。虽然一些药物已经被用于有效治疗普通人群的骨质疏松症。

防治骨质流失，这些“小药物”要科学使用！

急性骨丢失一般发生在急性制动或卧床后6-8周，骨量急剧下降到最低水平，是预期骨折风险最高的时期；急性骨丢失容易引起骨质疏松、骨折固定、关节置换失败等。那么发生骨丢失该如何防治？

JBMR:Odanacatib 对患有骨质疏松症的绝经后妇女骨结构和质量的影响

Odanacatib (ODN) 是一种口服选择性组织蛋白酶 K (CatK) 抑制剂，它可以在不减少破骨细胞数量的情况下抑制 CatK，从而抑制骨吸收。

Heart：女性补钙要抓紧，骨质疏松或将影响心血管健康！

近日，来自韩国首尔大学的研究团队在《Heart》杂志发表了一篇题为 Prognostic value of lower bone mineral density in predicting adver

Baidu
map
Baidu
map
Baidu
map